Adamis Pharmaceuticals Corp 4
4 · Adamis Pharmaceuticals Corp · Filed May 27, 2016
Insider Transaction Report
Form 4
Glover Eddie Wabern
CEO of U.S. Compounding, Inc.
Transactions
- Award
Employee Stock Option (right to buy)
2016-05-25+70,000→ 70,000 totalExercise: $8.46Exp: 2026-05-25→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable as to one-sixth of the option shares on the six-month anniversary of the grant date, and thereafter as to 1/36 of the option shares on each monthly anniversary of the grant date commencing with the seven-month anniversary of the grant date.